

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment
We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.
The realization of this publication represents a milestone and praise the inestimable contributes of two important researcher: Dr. Federico Martinelli (Department of Biology, Università degli studi di Firenze, Firenze, Italy) and Dr. Anna Perrone (Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy) .
The article evaluates the pandemic we’re living and the screening methodologies available at the moment proposing the bCUBE as a viable alternative for a quick and simple detection of this virus in humans.
-
Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
-
Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2
-
Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich
-
A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.
-
Hyris and its network want to make pragmatic impact Helping Ukrainian Families
-
Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.